Literature DB >> 18953558

Tumor-host interactions: the role of inflammation.

Marie-Aude Le Bitoux1, Ivan Stamenkovic.   

Abstract

It is well established that interactions between tumor cells and the host tissue stroma play a key role in determining whether and how any given solid malignancy will develop. In most cases, tumor cells hijack stromal cell functions for their own benefit and ultimately dictate the rules of engagement to the host tissue microenvironment. However, the contribution of the different stromal cell components to tumor growth remains to be clarified. Because most solid tumors are accompanied by a local inflammatory response, it has long been thought that inflammation and carcinogenesis are related. If formal proof that cancer can be initiated by inflammation in the absence of exogenous carcinogens is still lacking, there is abundant evidence that the inflammatory response can play a central role in modulating tumor growth and progression. This review will discuss some of the mechanisms whereby inflammation can both enhance and inhibit tumor growth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18953558     DOI: 10.1007/s00418-008-0527-3

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  83 in total

1.  Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOP.

Authors:  Minna Taskinen; Marja-Liisa Karjalainen-Lindsberg; Sirpa Leppä
Journal:  Blood       Date:  2008-02-28       Impact factor: 22.113

Review 2.  Wnt/beta-catenin signaling in cancer stemness and malignant behavior.

Authors:  Riccardo Fodde; Thomas Brabletz
Journal:  Curr Opin Cell Biol       Date:  2007-02-16       Impact factor: 8.382

Review 3.  Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.

Authors:  Alaa Rostom; Catherine Dubé; Gabriela Lewin; Alexander Tsertsvadze; Nicholas Barrowman; Catherine Code; Margaret Sampson; David Moher
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

Review 4.  The inflammasome, autoinflammatory diseases, and gout.

Authors:  Virginie Pétrilli; Fabio Martinon
Journal:  Joint Bone Spine       Date:  2007-08-21       Impact factor: 4.929

5.  Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.

Authors:  Osamu Kawai; Genichiro Ishii; Kaoru Kubota; Yukinori Murata; Yoichi Naito; Tetsuya Mizuno; Keiju Aokage; Nagahiro Saijo; Yutaka Nishiwaki; Akihiko Gemma; Syoji Kudoh; Atsushi Ochiai
Journal:  Cancer       Date:  2008-09-15       Impact factor: 6.860

Review 6.  Tumour immunity: effector response to tumour and role of the microenvironment.

Authors:  Alberto Mantovani; Pedro Romero; A Karolina Palucka; Francesco M Marincola
Journal:  Lancet       Date:  2008-02-13       Impact factor: 79.321

Review 7.  NLRs at the intersection of cell death and immunity.

Authors:  Jenny P-Y Ting; Stephen B Willingham; Daniel T Bergstralh
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

Review 8.  IL-1, IL-18, and IL-33 families of cytokines.

Authors:  William P Arend; Gaby Palmer; Cem Gabay
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

Review 9.  TNF-alpha in promotion and progression of cancer.

Authors:  Frances Balkwill
Journal:  Cancer Metastasis Rev       Date:  2006-09       Impact factor: 9.264

10.  Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.

Authors:  A F Olumi; G D Grossfeld; S W Hayward; P R Carroll; T D Tlsty; G R Cunha
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

View more
  37 in total

1.  Inflammation and cancer.

Authors:  Noemí Eiró; Francisco J Vizoso
Journal:  World J Gastrointest Surg       Date:  2012-03-27

Review 2.  State-of-the-art technologies, current opinions and developments, and novel findings: news from the field of histochemistry and cell biology.

Authors:  Esther Asan; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2008-11-05       Impact factor: 4.304

Review 3.  Extending the knowledge in histochemistry and cell biology.

Authors:  Wolfgang-Moritz Heupel; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2009-11-28       Impact factor: 4.304

Review 4.  Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer.

Authors:  Geetha Srikrishna; Hudson H Freeze
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

Review 5.  Thrombocytosis as a prognostic marker in gastrointestinal cancers.

Authors:  Ioannis A Voutsadakis
Journal:  World J Gastrointest Oncol       Date:  2014-02-15

6.  Accumulation of CD1a-positive Langerhans cells and mast cells in actinic cheilitis.

Authors:  Caliandra Pinto Araújo; Clarissa Araújo Silva Gurgel; Eduardo Antônio Gonçalves Ramos; Valéria Souza Freitas; Aryon de Almeida Barbosa; Luciana Maria Pedreira Ramalho; Jean Nunes dos Santos
Journal:  J Mol Histol       Date:  2010-10-02       Impact factor: 2.611

7.  p38 mitogen-activated protein kinase interacts with vinculin at focal adhesions during fatty acid-stimulated cell adhesion.

Authors:  Margaret D George; Robert N Wine; Brad Lackford; Grace E Kissling; Steven K Akiyama; Kenneth Olden; John D Roberts
Journal:  Biochem Cell Biol       Date:  2013-06-24       Impact factor: 3.626

8.  Principles of modular tumor therapy.

Authors:  Albrecht Reichle; Gerhard C Hildebrandt
Journal:  Cancer Microenviron       Date:  2009-07-11

9.  Diclofenac inhibits tumor growth in a murine model of pancreatic cancer by modulation of VEGF levels and arginase activity.

Authors:  Nina Mayorek; Nili Naftali-Shani; Myriam Grunewald
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

Review 10.  Why target the tumor stroma in melanoma?

Authors:  James Hutchenreuther; Andrew Leask
Journal:  J Cell Commun Signal       Date:  2017-11-06       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.